TITLE

Enhanced Binding of HLF/DBP Heterodimers Represents One Mechanism of PAR Protein Transactivation of the Factor VIII and Factor IX Genes

AUTHOR(S)
Begbie, Megan; Mueller, Christopher; Lillicrap, David
PUB. DATE
February 1999
SOURCE
DNA & Cell Biology;Feb99, Vol. 18 Issue 2, p165
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The regulatory regions of the genes for coagulation Factors VIII and IX contain binding sites for both liverenriched and ubiquitous transcriptional regulators. We investigated the role of the liver-enriched protein, hepatic leukemia factor (HLF), in mediating transcriptional regulation of the Factor VIII and IX genes. Using transient transfection assays in HepG2 hepatoma cells, we demonstrated the ability of HLF alone and in synergistic combination with the D-box binding protein (DBP), another proline and acidic-rich (PAR) protein family member, to transactivate these promoters. HLF is capable of binding to multiple sites in both the Factor VIII and Factor IX promoters. At least some of the synergistic activation of the Factor VIII promoter seen with HLF and DBP cotransfection can be attributed to increased binding of HLF-DBP heterodimers to two Factor VIII promoter sites. We have also demonstrated that an E2A-HLF chimera, derived from a t(17;19) translocation in pre-B acute lymphoblastic leukemia (ALL) cells, is capable of mediating expression from the Factor VIII and Factor IX promoters in both hepatoma cells and pre-B ALL cells. These observations indicate that the PAR family of transcription factors plays an important and complex role in regulating expression of the Factor VIII and Factor IX genes, involving the binding of both homodimeric and heterodimeric complexes of HLF and DBP to several sites in the promoters. Finally, these studies reaffirm the potential role of dimeric transcription factor complexes in mediating interactions with specific promoter elements, which, in the case of the Factor VIII promoter, results in dramatically enhanced binding of HLF-DBP heterodimers to two cis-acting sequences. These observations further our understanding of the role played by members ofthe PAR family of transcription factors in regulating expression of the Factor VIII and Factor IX genes.
ACCESSION #
6463008

 

Related Articles

  • Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Fletcher, M.L.; Trowell, J.M.; Craske, J.; Pavier, K.; Rizza, C.R. // British Medical Journal (Clinical Research Edition);12/10/1983, Vol. 287 Issue 6407, p1754 

    Investigates the patients received the treatment with coagulation factor after the transfusion of factor VIII. Performance of liver function tests; Increase of serum transaminase activities; Patient not treated developed non-A non-B hepatitis virus.

  • Acyclic Identification of Aptamers for Human alpha-Thrombin Using Over-Represented Libraries and Deep Sequencing. Kupakuwana, Gillian V.; Crill II, James E.; McPike, Mark P.; Borer, Philip N. // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Background: Aptamers are oligonucleotides that bind proteins and other targets with high affinity and selectivity. Twenty years ago elements of natural selection were adapted to in vitro selection in order to distinguish aptamers among randomized sequence libraries. The primary bottleneck in...

  • Plasma Fibrinogen in Health and Disease. Ansari, Azam; Silvis, Stephen E. // American Journal of Gastroenterology;Jan1972, Vol. 57 Issue 1, p13 

    Plasma fibrinogen was quantitatively measured by Quick's method in 12 normal male subjects (Group I) and in 102 male patients who were classified in five different groups (Groups II-VI). The mean plasma fibrinogen level of Group I was 372.4 ± 66.5 mg. per cent; of Group II (22 patients with...

  • Differentiation of embryonic stem cells into hepatocytes that coexpress coagulation factors VIII and IX. Jun CAO; Chang-zhen SHANG; Li-hong LÜ; De-chuan QIU; Meng REN; Ya-jin CHEN; Jun MIN // Acta Pharmacologica Sinica;Nov2010, Vol. 31 Issue 11, p1478 

    Aim:To establish an efficient culture system to support embryonic stem (ES) cell differentiation into hepatocytes that coexpress F-VIII and F-IX.Methods:Mouse E14 ES cells were cultured in differentiation medium containing sodium butyrate (SB), basic fibroblast growth factor (bFGF), and/or bone...

  • HEMORRHAGIC DIATHESES DURING AND AFTER PORTACAVAL SHUNTS IN PATIENTS WITH CIRRHOSIS OF THE LIVER; THEIR RECOGNITION AND MANAGEMENT. Grossi, Carlo E.; Rousselot, Louis M.; Panke, William F. // American Journal of Gastroenterology;Feb1964, Vol. 41 Issue 2, p117 

    Discusses the findings of a study on the hemorrhagic diatheses during and after portacaval shunts in patients with cirrhosis of the liver. Study of coagulation factors during patients' bleeding from esophageal varices; Analysis of plasma of patients; Incidence of fibrinolytic activity in patients.

  • Vascular Invasion and Herniation by Hepatocellular Carcinoma in Cirrhosis. Quaglia, Alberto; Etessami, Nazanin; Sim, Rosalind; Difford, John; Dhillon, A. P. // Archives of Pathology & Laboratory Medicine;May2005, Vol. 129 Issue 5, p639 

    Context-Vascular invasion is an important diagnostic and prognostic feature of hepatocellular carcinoma (HCC) in cirrhosis. Intravascular free-floating tumor clusters (IvCs) of HCC are found histologically in the vicinity of HCC. Thrombus formation is not seen morphologically in association with...

  • KaraciÄŸer hastalıklarında pıhtılaÅŸma-tromboz mekanizmasına neler oluyor? Tiraje Celkan, Tülin // Turkish Pediatrics Archive / Turk Pediatri Arsivi;Jun2013, Vol. 48 Issue 2, p94 

    Children with liver disease present complex and varied acquired coagulation abnormalities. Liver is the place where clotting factors are produced as well as inhibitors of coagulation and fibrinolytic system components. Although 75-85% of patients with liver disease show abnormal laboratory...

  • Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene. Kong, Minyoung; Kim, Younyoung; Lee, Chaeyoung // Molecular Biology Reports;Apr2014, Vol. 41 Issue 4, p2015 

    Coagulation factor XI (FXI) is essential for normal function of the intrinsic pathway of blood coagulation. A nucleotide variant (rs3756008) in the promoter region of the FXI gene was recently reported for association with venous thromboembolism. This study aimed to examine promoter activity of...

  • MEDICAL CONDITIONS ASSOCIATED WITH PROLONGED ACTIVATED PARTIAL THROMBOPLASTIN TIME IN SWAT. Shah, Mukamil; Khattak, Imran ud Din; Khattak, Sania Tanweer; Ahad, Abdul; Mahsud, Muhammad Amin Jan // Gomal Journal of Medical Sciences;Jan2011, Vol. 9 Issue 1, p15 

    Background: APPT is a commonly requested laboratory test in various bleeding conditions and as a screening test preoperatively. It is also used to monitor heparin therapy. This study was conducted to see the frequency of various medical conditions presenting with prolonged activated partial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics